Early Phase 1
Completed N=219
Gabapentin for Perioperative Pain Relief in Surgical Abortion
Pain Control
Source: ClinicalTrials.gov NCT04292171 ↗
Enrolled (actual)
219
Serious AEs
0.0%
Results posted
Dec 2020
Primary outcomePrimary: Pain Score — 17; 17 score on a scale
Summary
Gabapentin preoperative use for evaluation of benefit to reduce pain during and after surgical office-based abortion.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Pain Score |
17; 17 | — |
| SECONDARY Pain Score 24 |
0; 1 | — |
| SECONDARY Nausea |
1.74; 1.74 | — |
| SECONDARY Vomiting |
0.85; 0.74 | — |
| SECONDARY Pain Score at 30 Minutes Postoperative |
20; 23 | — |
Eligibility Criteria
Inclusion Criteria
- Women seeking surgical abortion between 5 and 23 6/7 weeks of ultrasound age.
- English or Spanish speaking
- eligible for office-based surgical pregnancy termination
Exclusion Criteria
- present use of gabapentin or pregabalin,
- renal disease
- sensitivity or allergy to gabapentin
- Missed abortion
Data sourced from ClinicalTrials.gov (NCT04292171). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.